Pfizer (Germany) Insiders
| PFE Stock | 25.22 0.37 1.49% |
Pfizer employs about 83 K people. The company is managed by 10 executives with a total tenure of roughly 193667 years, averaging almost 19366.0 years of service per executive, having 8300.0 employees per reported executive. Breaking down Pfizer's management performance can provide insight into the firm performance.
| John Young Insider Advisor |
| Jennifer Damico Insider Controller VP |
Pfizer |
Pfizer Management Team Effectiveness
The company has return on total asset (ROA) of 0.1287 % which means that it generated a profit of $0.1287 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3622 %, meaning that it generated $0.3622 on every $100 dollars invested by stockholders. Pfizer's management efficiency ratios could be used to measure how well Pfizer manages its routine affairs as well as how well it operates its assets and liabilities.Pfizer Workforce Comparison
Pfizer Inc is regarded fourth in number of employees category among its peers. The total workforce of Drug Manufacturers-General industry is at this time estimated at about 511,421. Pfizer retains roughly 83,000 in number of employees claiming about 16% of equities under Drug Manufacturers-General industry.
The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.39 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.39. Pfizer Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pfizer Inc Price Series Summation is a cross summation of Pfizer price series and its benchmark/peer.
Pfizer Notable Stakeholders
A Pfizer stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pfizer often face trade-offs trying to please all of them. Pfizer's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pfizer's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John Young | Advisor | Profile | |
| Jennifer Damico | Controller VP | Profile | |
| Christopher CFA | VP Officer | Profile | |
| DVM DVM | Chairman CEO | Profile | |
| Frank DAmelio | CFO VP | Profile | |
| Douglas Lankler | Exec Counsel | Profile | |
| Lidia Fonseca | Ex Officer | Profile | |
| Angela Hwang | Chief Bus | Profile | |
| Mikael MD | Dev Research | Profile | |
| David Denton | Chief VP | Profile |
About Pfizer Management Performance
The success or failure of an entity such as Pfizer Inc often depends on how effective the management is. Pfizer management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pfizer management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pfizer management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Pfizer's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pfizer Inc. Check Pfizer's Beneish M Score to see the likelihood of Pfizer's management manipulating its earnings.
Pfizer Workforce Analysis
Traditionally, organizations such as Pfizer use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pfizer within its industry.Pfizer Manpower Efficiency
Return on Pfizer Manpower
| Revenue Per Employee | 1.2M | |
| Revenue Per Executive | 10B | |
| Net Income Per Employee | 378K | |
| Net Income Per Executive | 3.1B |
Additional Tools for Pfizer Stock Analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.